Katalog der Deutschen Nationalbibliothek

Ihr Suchergebnis enthält zu viele Treffer. Bitte schränken Sie Ihre Suche weiter ein.

Ergebnis der Suche nach: "-3"
im Bestand: Gesamter Bestand

100001 - 100010 von 1000470

	100001	Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia Enthalten in Acta haematologica Bd. 145, 2022, Nr. 6: 619-626. 8 S.
	100002	Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology Practices Enthalten in Acta haematologica Bd. 145, 2022, Nr. 6: 603-610. 8 S.
	100003	Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion Cohort Enthalten in Acta haematologica Bd. 145, 2022, Nr. 6: 592-602. 11 S.
	100004	The Prognostic Impact of MYC Gene-Related Abnormalities on Multiple Myeloma Outcome through Fluorescence in situ Hybridization Analysis Enthalten in Acta haematologica Bd. 145, 2022, Nr. 6: 582-591. 10 S.
	100005	Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature Enthalten in Acta haematologica Bd. 145, 2022, Nr. 5: 566-570. 6 S.
	100006	A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations Enthalten in Acta haematologica Bd. 145, 2022, Nr. 5: 529-536. 8 S.
	100007	Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients Enthalten in Acta haematologica Bd. 145, 2022, Nr. 5: 499-504. 6 S.
	100008	Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes Enthalten in Acta haematologica Bd. 145, 2022, Nr. 4: 448-453. 6 S.
	100009	Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients Enthalten in Acta haematologica Bd. 145, 2022, Nr. 4: 440-447. 8 S.
	100010	Threshold of Serum Ferritin to Discriminate against Those at Greater Risk of Platelet Increase during Treatment with Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor Enthalten in Acta haematologica Bd. 145, 2022, Nr. 4: 412-418. 7 S.

100001 - 100010 von 1000470

Alle Materialarten > Artikel (1000470)

Alle Kataloge/Sammlungen

Alle Standorte

Aktionen